Study Discovers Dual Function of Neutrophils in Cancer Cells
Northwestern Medicine investigators have discovered how a particular type of immune cell exerts a dual function in cancer cells that is contingent on tumor grade.
Browsing: "Research"
Lakeside Discovery Supports Northwestern Lab to Treat Polycystic Kidney Disease
Lakeside Discovery, LLC, the collaboration between Northwestern University and Deerfield Management, will support the laboratory of Paul DeCaen, PhD in a multi-year partnership to advance new therapies for genetically driven polycystic kidney disease.
The XX/XY Factor
A massive trove of information produced in a Northwestern-led study will lay the groundwork for understanding sex-related differences in health and disease for decades to come.
Miller Receives Biomaterials Award for Celiac Disease Nanoparticle Therapy
Stephen Miller, PhD, received the 2021 Technology Innovation and Development Award from the Society For Biomaterials for work on a nanoparticle that induces gluten tolerance in celiac disease.
Mapping Neural Connections in Parkinson’s Disease
Imbalanced activation of cells and previously unknown neural connections may be responsible for some motor symptoms in Parkinson’s disease and similar neurodegenerative conditions, according to two recent studies.
Inhibiting SAM Biosynthesis to Slow Tumor Growth
Inhibiting production of a key material produced by the mTOR pathway could slow tumor growth, according to a recent Northwestern Medicine study.
No Pain, No Gain in Exercise for Peripheral Artery Disease
A Northwestern Medicine study has shown that a high-intensity home-based walking exercise program improved walking ability in people with peripheral artery disease.
Expansion of 2GETHER Project Awarded $9 Million
The Institute for Sexual and Gender Minority Health and Wellbeing has been awarded a five-year, $9 million for the expansion of the 2GETHER study, which aims to reduce HIV incidence by teaching relationship and sexual health promotion skills to young men who have sex with men.
Protein Variant May Have Potential as Target for Glioblastoma
Inhibiting a novel protein variant within glioma stem cells may be a promising therapeutic approach to treat glioblastoma, according to a recent Northwestern Medicine study.
Feinberg Investigators Discuss Impact and Evolution of COVID-19
It’s been one year since the first case of COVID-19 was detected in the United States, and still Feinberg investigators continue to investigate the disease, its evolution and its impact on society.